pubmed-article:20532262 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20532262 | lifeskim:mentions | umls-concept:C0020286 | lld:lifeskim |
pubmed-article:20532262 | lifeskim:mentions | umls-concept:C0034255 | lld:lifeskim |
pubmed-article:20532262 | lifeskim:mentions | umls-concept:C0034424 | lld:lifeskim |
pubmed-article:20532262 | lifeskim:mentions | umls-concept:C0175921 | lld:lifeskim |
pubmed-article:20532262 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
pubmed-article:20532262 | pubmed:issue | 15 | lld:pubmed |
pubmed-article:20532262 | pubmed:dateCreated | 2010-7-15 | lld:pubmed |
pubmed-article:20532262 | pubmed:abstractText | The combination of the readily available chiral bisphosphine ligand Difluorphos with [Ir(COD)Cl](2) in THF resulted in a highly efficient catalyst system for asymmetric hydrogenation of quinolines at quite low catalyst loadings (0.05-0.002 mol%), affording the corresponding products with high enantioselectivities (up to 96%), excellent catalytic activities (TOF up to 3510 h(-1)) and productivities (TON up to 43000). The same catalyst was also successfully applied to the asymmetric hydrogenation of trisubstituted pyridines with nearly quantitative yields and up to 98% ee. In these two reactions, the addition of I(2) additive is indispensable; but the amount of I(2) has a different effect on catalytic performance. | lld:pubmed |
pubmed-article:20532262 | pubmed:language | eng | lld:pubmed |
pubmed-article:20532262 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20532262 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20532262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20532262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20532262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20532262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20532262 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20532262 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20532262 | pubmed:month | Aug | lld:pubmed |
pubmed-article:20532262 | pubmed:issn | 1477-0539 | lld:pubmed |
pubmed-article:20532262 | pubmed:author | pubmed-author:ChanAlbert... | lld:pubmed |
pubmed-article:20532262 | pubmed:author | pubmed-author:WangTianliT | lld:pubmed |
pubmed-article:20532262 | pubmed:author | pubmed-author:TangWeijunW | lld:pubmed |
pubmed-article:20532262 | pubmed:author | pubmed-author:SunYaweiY | lld:pubmed |
pubmed-article:20532262 | pubmed:author | pubmed-author:LamKim-HungKH | lld:pubmed |
pubmed-article:20532262 | pubmed:author | pubmed-author:Lijin Xu | lld:pubmed |
pubmed-article:20532262 | pubmed:author | pubmed-author:Qinghua Fan | lld:pubmed |
pubmed-article:20532262 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20532262 | pubmed:day | 7 | lld:pubmed |
pubmed-article:20532262 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:20532262 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20532262 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20532262 | pubmed:pagination | 3464-71 | lld:pubmed |
pubmed-article:20532262 | pubmed:meshHeading | pubmed-meshheading:20532262... | lld:pubmed |
pubmed-article:20532262 | pubmed:meshHeading | pubmed-meshheading:20532262... | lld:pubmed |
pubmed-article:20532262 | pubmed:meshHeading | pubmed-meshheading:20532262... | lld:pubmed |
pubmed-article:20532262 | pubmed:meshHeading | pubmed-meshheading:20532262... | lld:pubmed |
pubmed-article:20532262 | pubmed:meshHeading | pubmed-meshheading:20532262... | lld:pubmed |
pubmed-article:20532262 | pubmed:meshHeading | pubmed-meshheading:20532262... | lld:pubmed |
pubmed-article:20532262 | pubmed:meshHeading | pubmed-meshheading:20532262... | lld:pubmed |
pubmed-article:20532262 | pubmed:meshHeading | pubmed-meshheading:20532262... | lld:pubmed |
pubmed-article:20532262 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20532262 | pubmed:articleTitle | Highly efficient and enantioselective hydrogenation of quinolines and pyridines with Ir-Difluorphos catalyst. | lld:pubmed |
pubmed-article:20532262 | pubmed:affiliation | Department of Chemistry, Renmin University of China, Beijing 100872, China. | lld:pubmed |
pubmed-article:20532262 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20532262 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |